New medical technology figure on European Commission vows to cut red tape:
This article was originally published in Clinica
Gunter Verheugen, the new Commissioner for industry and enterprise at the European Commission, whose brief includes overseeing the Commission's medical device and diagnostics unit, has spoken out in support of a new bid by the European Council to cut red tape. During a meeting of economy ministers for a competitiveness council, held on November 25, ministers agreed to simplify existing regulations in several areas including healthcare, social policy and the environment. Mr Verheugen said that the fight against EU bureaucracy is a key priority for him and that he hopes it will become his "personal trademark over the next five years".
You may also be interested in...
Deal Snapshot: AstraZeneca has sublicensed global rights to its peripheral mu-opioid receptor antagonist to RedHill Biopharma, excluding Europe, Canada and Israel, with RedHill also separately receiving non-dilutive financing from HealthCare Royalty Partners.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.